ATXI
Avenue Therapeutics, Inc. Common Stock
ATXI
ATXI
Delisted
ATXI was delisted on the 18th of March, 2025.
5 hedge funds and large institutions have $517K invested in Avenue Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$148K | |
| 2 | +$70.2K | |
| 3 | +$58K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$35K |
Top Sellers
| 1 | -$258K | |
| 2 | -$89K | |
| 3 | -$69K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$41K |
| 5 |
Morgan Stanley
New York
|
-$4K |